Prognostic Value of a Modified Albumin–Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.

MLA

Shinozuka, Takahiro, et al. “Prognostic Value of a Modified Albumin–Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.” Annals of Surgical Oncology: An Oncology Journal for Surgeons, vol. 29, no. 8, Aug. 2022, pp. 4889–96. EBSCOhost, https://doi.org/10.1245/s10434-022-11654-6.

APA

Shinozuka, T., Kanda, M., Shimizu, D., Tanaka, C., Inokawa, Y., Hattori, N., Hayashi, M., Koike, M., & Kodera, Y. (2022). Prognostic Value of a Modified Albumin–Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection. Annals of Surgical Oncology: An Oncology Journal for Surgeons, 29(8), 4889–4896. https://doi.org/10.1245/s10434-022-11654-6

Chicago

Shinozuka, Takahiro, Mitsuro Kanda, Dai Shimizu, Chie Tanaka, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Masahiko Koike, and Yasuhiro Kodera. 2022. “Prognostic Value of a Modified Albumin–Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.” Annals of Surgical Oncology: An Oncology Journal for Surgeons 29 (8): 4889–96. doi:10.1245/s10434-022-11654-6.